Researchers develop a protocol to boost the effectiveness of and reduce the risk of potential side effects for T cell cancer therapies.
Cancer genetics experts say new technologies and more comprehensive data collection are required to deepen our understanding of tumour lifecycles.
Researchers have pieced together a series of molecular events that trigger the progression of chronic myeloid leukemia to its acute phase—the ‘blast crisis.’
Disruption of the methionine cycle in tumor-initiating cells disarms their tumorigenic capabilities, researchers say.
State-of-the-art single-cell RNA sequencing technologies shed light on the mechanisms through which cancer cells become resistant to tumor-treating drugs
A dual-function protein switch can be tweaked to improve the effectiveness of cellular reprogramming
Molecular dissection of bile duct cancer reveals subtypes with different origins and varying potential treatments
discover a master regulator of nose development
First roadmap of stomach cancer super-enhancers paves the way for new treatments.
A sensitive DNA profiling technique could improve scientists’ approach to fighting cancer drug resistance
A neglected histone modification has unexpected implications for gene activity